NEW YORK — South Korean diagnostics firm Bioneer said on Wednesday that it has received CE-IVD marking for two combination tests for SARS-CoV-2 and influenza.
The AccuPower RV1 Real-Time RT-PCR Kit and the AccuPower RV1 Multiplex Kit are both designed to detect the E, RdRp, and N genes of SARS-CoV-2, as well as influenza A and B, in a single nasopharyngeal or oropharyngeal sample.